CVE-2022-1521criticalCWE-284

CVE-2022-1521: critical vulnerability in Illumina iSeq 100 Instrument

3.2.4 IMPROPER ACCESS CONTROL CWE-284

Published · Updated

Follow this CVE+ Monitor iSeq 100 Instrument+ Monitor MiniSeq Instrument

E-mail alert when it lands in KEV, gets a public PoC or its score goes up.

28Vexday Risk Score

No sign of exploitation. No public exploitation artifact known so far.

ssvc Trackcvss 9.1epss 1.1%
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Affected products
Illumina · iSeq 100 InstrumentIllumina · MiniSeq InstrumentIllumina · MiSeq DxIllumina · MiSeq InstrumentIllumina · NextSeq 500 InstrumenIllumina · NextSeq 550DxIllumina · NextSeq 550 Instrument
Related CVEs — Illumina iSeq 100 Instrument

In the same product, most dangerous first.

CVE-2022-1517CRITICAL3.2.1 EXECUTION WITH UNNECESSARY PRIVILEGES CWE-250EPSS 1.8%CVE-2022-1518CRITICAL3.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22EPSS 1.7%CVE-2022-1519CRITICALCVE-2022-1519EPSS 1.4%CVE-2022-1524HIGH3.2.5 CLEARTEXT TRANSMISSION OF SENSITIVE INFORMATION CWE-319EPSS 0.3%